跳至内容
· 生物活化
SKU 13756

Sunekos Cell 15

有货
制造商
Professional Dietetics S.p.A.
产地
意大利
批发价及价格历史仅对已验证账户开放
allpara 仅向持证从业者供货。请登录或申请 B2B 账户,查看实时价格、批量阶梯价及价格历史。

Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.

主要优势: Sunekos Cell 15

  • CE-marked Class III medical device
  • Promotes optimisation of extracellular matrix protein turnover
  • Supports neo-collagenesis rather than collagenase
  • Helps improve microcirculation
  • Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
  • Helps regulate physiological pH
  • Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
  • Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
关键信息
品牌 Sunekos
制造商 Professional Dietetics S.p.A.
原产国 Italy
认证 CE-marked Class III medical device
成分 Low molecular weight (200 kD) sodium hyaluronate with the patented HY6AA amino acid formula (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine), plus carbonate and bicarbonate salts that rebalance the acidosis of the latent inflammation seen in both early and late stage cellulite
容量 / 规格 15 ml per reconstituted treatment pack
包装 1 treatment pack of 15 ml to be reconstituted: 1 vial of carbonate/bicarbonate and 1 bottle of low molecular weight sodium hyaluronate with amino acids
针头规格 ATL-n needle technique (stages I and II): 30 G, 12 mm. ATL-c cannula technique (stages III and IV): 27 G, 40-50 mm, or 22 G, 50-70 mm.
使用类型 Professional use only, by qualified practitioners. Supplied as a pack to be reconstituted before use.
注射深度 ATL-n needle technique, for stages I and II: medium-deep dermis, needle inclination 30 degrees, 0.15 ml per point, perpendicular to the folding lines. ATL-c cannula technique, for stages III and IV: deep dermis injection, fan technique, 0.8 ml per injection.
方案 / 疗程 Injection scheme: 3 areas per side at 2.5 ml per area, giving 7.5 ml per leg.

适应症与专业用途

主要适应症

  • Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
  • Cellulite stages I and II
  • Cellulite stages III and IV
  • Fibrosis and extracellular matrix inflammation associated with cellulite
  • Impaired microcirculation associated with cellulite

专业用途

Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.

治疗部位

  • Cellulite-affected areas of the thighs and gluteal/trochanteric region

适用患者

Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.

作用原理: Sunekos Cell 15 ​

Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 SUNEKOS 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。

常见问题

Which cellulite stages does Sunekos Cell 15 treat?

Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.

How does Sunekos Cell 15 differ from lipolytic cellulite treatments?

Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.

Why does Sunekos Cell 15 include an alkaline solution?

The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.

更多产品: Professional Dietetics

查看制造商

诊所替代选择

全部产品

Sunekos Cell 15

有货
CE认证 CE认证 Sunekos Cell 15
仅限已验证账户查看价格
请登录或申请 B2B 账户以查看您的价格。
申请 B2B 账户

Sunekos Cell 15 is an injectable cellulite treatment by Sunekos, developed around the extracellular matrix rather than the fat cell. It is suitable for qualified practitioners treating cellulite, framed as Edematous Fibrosclerotic Panniculopathy, across stages I to IV. The product relies on a synergy of hyaluronic acid, amino acids and an alkaline solution in a non-lipoclastic, non-lipolytic approach and is intended for professional use.

主要优势: Sunekos Cell 15

  • CE-marked Class III medical device
  • Promotes optimisation of extracellular matrix protein turnover
  • Supports neo-collagenesis rather than collagenase
  • Helps improve microcirculation
  • Helps reduce fibrosis by re-equilibrating extracellular matrix inflammation
  • Helps regulate physiological pH
  • Non-invasive, non-lipoclastic and non-lipolytic approach focused on restructuring the extracellular matrix
  • Supported by a preliminary study on 25 subjects reporting a reduction in clinical evaluation score in both cellulite stage groups
关键信息
品牌 Sunekos
制造商 Professional Dietetics S.p.A.
原产国 Italy
认证 CE-marked Class III medical device
成分 Low molecular weight (200 kD) sodium hyaluronate with the patented HY6AA amino acid formula (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine), plus carbonate and bicarbonate salts that rebalance the acidosis of the latent inflammation seen in both early and late stage cellulite
容量 / 规格 15 ml per reconstituted treatment pack
包装 1 treatment pack of 15 ml to be reconstituted: 1 vial of carbonate/bicarbonate and 1 bottle of low molecular weight sodium hyaluronate with amino acids
针头规格 ATL-n needle technique (stages I and II): 30 G, 12 mm. ATL-c cannula technique (stages III and IV): 27 G, 40-50 mm, or 22 G, 50-70 mm.
使用类型 Professional use only, by qualified practitioners. Supplied as a pack to be reconstituted before use.
注射深度 ATL-n needle technique, for stages I and II: medium-deep dermis, needle inclination 30 degrees, 0.15 ml per point, perpendicular to the folding lines. ATL-c cannula technique, for stages III and IV: deep dermis injection, fan technique, 0.8 ml per injection.
方案 / 疗程 Injection scheme: 3 areas per side at 2.5 ml per area, giving 7.5 ml per leg.

适应症与专业用途

主要适应症

  • Cellulite, framed as Edematous Fibrosclerotic Panniculopathy (EFP)
  • Cellulite stages I and II
  • Cellulite stages III and IV
  • Fibrosis and extracellular matrix inflammation associated with cellulite
  • Impaired microcirculation associated with cellulite

专业用途

Sunekos Cell 15 is a CE-marked Class III medical device intended for medical-practitioner use only. It is supplied as a two-component treatment pack that is reconstituted before use, combining low-molecular-weight sodium hyaluronate and amino acids with carbonate/bicarbonate salts.

治疗部位

  • Cellulite-affected areas of the thighs and gluteal/trochanteric region

适用患者

Sunekos Cell 15 is intended for adult patients presenting with cellulite / Edematous Fibrosclerotic Panniculopathy (EFP), including stages I–IV. A preliminary clinical evaluation included 25 subjects, with 11 in stages I–II and 14 in stages III–IV.

作用原理: Sunekos Cell 15 ​

Sunekos Cell 15 works through a synergy of hyaluronic acid, amino acids and an alkaline solution. Where earlier intradermal approaches to cellulite mainly addressed edema and microcirculation, this combination also targets the extracellular matrix: it is designed to optimise extracellular matrix protein turnover, improve microcirculation, reduce fibrosis by re-equilibrating matrix inflammation and help regulate physiological pH. The approach is non-lipoclastic and non-lipolytic, rebuilding rather than destroying, which makes it suitable for restoring skin and adipose tissue homeostasis rather than breaking down fat.

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 SUNEKOS 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。

常见问题

Which cellulite stages does Sunekos Cell 15 treat?

Sunekos Cell 15 shows indications for cellulite stages I and II and for stages III and IV, with staging determined by the treating practitioner before treatment.

How does Sunekos Cell 15 differ from lipolytic cellulite treatments?

Sunekos Cell 15 is a non-lipoclastic and non-lipolytic approach. Instead of breaking down fat, it restructures the extracellular matrix, an approach of rebuilding rather than destroying.

Why does Sunekos Cell 15 include an alkaline solution?

The alkaline solution is part of the synergy that helps regulate physiological pH and re-equilibrate extracellular matrix inflammation, which helps reduce the fibrosis component of cellulite.

更多产品: Professional Dietetics

查看制造商 →
* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。